Apex Labs Doses First Patient in Take Home Psilocybin Clinical Trial ...Middle East

Canadian Veteran takes APEX-52, microdose, orally administered psilocybin drug product during APEX-002-A01-02 trial VANCOUVER, BC, Jan. 18, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of mental health care with psilocybin, is...

Hence then, the article about apex labs doses first patient in take home psilocybin clinical trial was published today ( Wednesday 18/01/2023 - 10:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Apex Labs Doses First Patient in Take Home Psilocybin Clinical Trial )

Also on site :

• AI-related layoffs a boost for stocks? Not necessarily
• Texas Roadhouse & Olive Garden among restaurants mandating strict ‘one ring’ policy for diner safety
• Alec Baldwin hits back at Elon Musk for criticizing Lupita Nyong’o’s looks amid ‘The Odyssey’ casting